GP KFPs / SAQs · womens-health
Abnormal uterine bleeding — KFP-style written assessment
KFP-style staged scenarios on abnormal uterine bleeding: the impact-based diagnosis, PALM-COEIN reasoning, investigation thresholds and biopsy triggers, the LNG-IUS-first medical ladder, surgical referral criteria, and iron co-management.
On this page
Study tools
Target exams
RACGP KFPRACGP AKTMRCGP AKT
Prompt
AUB: classify it with PALM-COEIN, investigate by risk not ritual, treat LNG-IUS-first — and never forget the iron
KFP 1 (10 marks)
A 43-year-old nurse reports two years of progressively heavy periods, now with clots flooding through protection on day 2–3, and fatigue. Cycles remain regular at 27 days. She is a non-smoker, BMI 29, takes no medication. Abdominal examination normal; speculum examination shows a healthy cervix; pregnancy test negative. Haemoglobin 104 g/L, MCV 72 fL, ferritin 8 ng/mL. [3] [21]
- State the diagnosis using FIGO's current definition, and name the co-diagnosis her blood results establish. (2) [3]
- Which investigations does NICE direct here, and which tests are explicitly avoided? (4) [21]
- Outline first-line management including the iron plan. (4) [21] [4]
Model answers
- Heavy menstrual bleeding by FIGO's impact-based definition: excessive menstrual blood loss interfering with quality of life regardless of measured volume. The bloods add iron-deficiency anaemia (Hb 104 g/L, microcytosis, ferritin 8 ng/mL) — a standard companion that changes treatment urgency but not the HMB label itself. [3]
- Full blood count is already done — mandatory for all women with HMB. Because examination is normal and there are no related symptoms (no IMB, no pelvic pain or pressure), NICE permits starting pharmacological treatment without further investigation; if investigating anyway, hysteroscopy versus ultrasound is chosen by history and examination. Avoided tests: female hormone testing, thyroid testing without thyroid symptoms, blind endometrial biopsy, D&C as a diagnostic tool. Ferritin was appropriate given suspected deficiency. [21]
- Offer an LNG-IUS as first treatment — she has no identified pathology — explaining expected bleeding change over initial cycles lasting possibly beyond six months, and waiting at least six cycles to judge benefit. Start oral iron concurrently for the deficiency, rechecking haemoglobin and ferritin to confirm repletion. If she declines the LNG-IUS, offer tranexamic acid and/or NSAIDs during menses (non-hormonal) or combined hormonal contraception/cyclical progestogens (hormonal). [21] [4]
References9ShowHide
- [2]Munro MG, Critchley HO, Fraser IS et al. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertility and sterility, 2011.PMID 21496802
- [3]Bofill Rodriguez M, Dias S, Jordan V et al. Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis. The Cochrane database of systematic reviews, 2022.PMID 35638592
- [4]Bofill Rodriguez M, Lethaby A, Jordan V Progestogen-releasing intrauterine systems for heavy menstrual bleeding. The Cochrane database of systematic reviews, 2020.PMID 32529637
- [6]Bofill Rodriguez M, Lethaby A, Low C et al. Cyclical progestogens for heavy menstrual bleeding. The Cochrane database of systematic reviews, 2019.PMID 31425626
- [9]Bofill Rodriguez M, Lethaby A, Grigore M et al. Endometrial resection and ablation techniques for heavy menstrual bleeding. The Cochrane database of systematic reviews, 2019.PMID 30667064
- [12]Oliveira JA, Eskandar K, Chagas J et al. Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis. Contraception, 2024.PMID 38614274
- [13]Gupta S, Castaman G, Funkhouser K et al. Call to action: identifying an underlying bleeding disorder in adolescents with heavy menstrual bleeding. Research and practice in thrombosis and haemostasis, 2026.PMID 42598146
- [18]Jaya-Bodestyne SL, Goh MS, Gwan MCH et al. To do or not to do? - Endometrial biopsy in younger women with abnormal uterine bleeding. European journal of obstetrics, gynecology, and reproductive biology. X, 2025.PMID 39981415
- [21]Munro MG, Critchley HOD, Fraser IS et al. Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2. International journal of gynaecology and obstetrics, 2023.PMID 37538019